Skip to main content
Log in

Association of Genetic Variations in RTN4 3’-UTR with Risk of Uterine Leiomyomas

  • Research
  • Published:
Pathology & Oncology Research

Abstract

This pilot case-control study was conducted to test the hypothesis that the TATC (rs71682890) and CAA (rs34917480) insertion/deletion polymorphisms of RTN4 3’-UTR are associated with the susceptibility to uterine leiomyoma (UL). The study recruited 286 premenopausal women with UL and 450 unrelated postmenopausal women not presenting the disease as control subjects. The polymorphisms of rs71682890 and rs34917480 were genotyped with the method of polymerase chain reaction polyacrylamide gel electrophoresis (PCR - PAGE). No statistically significant association was observed between the TATC insertion/deletion polymorphism and UL risk. However, increased UL risk was identified to be significantly associated with CAA insertion/deletion polymorphism in the recessive and codominant model. The present study provided evidence for the first time that CAA polymorphism in RTN4 3’-UTR, but not TATC polymorphism may be involved in susceptibility to UL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Duhan N (2011) Current and emerging treatments for uterine myoma - an update. Int J Womens Health 3:231–241

    Article  PubMed  Google Scholar 

  2. Hart RKY, Yeong CT, Seed P, Taylor A, Braude P (2001) A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod 16:2411–2417

    CAS  PubMed  Google Scholar 

  3. Ptacek TSC, Walker CL, Sell SM (2007) Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene. Cancer Genet Cytogenet 174:116–120

    Article  CAS  PubMed  Google Scholar 

  4. Morgan Ortiz FPRB, Elorriaga García E, Báez Barraza J, Quevedo Castro E, Peraza Garay Fde J (2011) Uterine leiomyomas during pregnancy and its impact on obstetric outcome. Ginecol Obstet Mex 79(8):467–473

    PubMed  Google Scholar 

  5. Lee EJ, Kong G, Lee SH, Rho SB, Park CS, Kim BG, Bae DS, Kavanagh JJ, Lee JH (2005) Profiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer 15(1):146–154. doi:10.1111/j.1048-891x.2005.15016.x

    Article  PubMed  Google Scholar 

  6. Flynn MJM, Datta S, Myers E (2006) Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol 195(4):955–964

    Article  PubMed  Google Scholar 

  7. Luoto RKJ, Rutanen EM, Taipale P, Perola M, Koskenvuo M (2000) Heritability and risk factors of uterine fibroids–the Finnish Twin Cohort study. Maturitas 37(1):15–26

    Article  CAS  PubMed  Google Scholar 

  8. Chen Y, Tang X, Cao X, Chen H, Zhang X (2006) Human Nogo-C overexpression induces HEK293 cell apoptosis via a mechanism that involves JNK-c-Jun pathway. Biochem Biophys Res Commun 348(3):923–928. doi:10.1016/j.bbrc.2006.07.166

    Article  CAS  PubMed  Google Scholar 

  9. Shimakage MIN, Ohshima K, Kawahara K, Oka T, Yasui K, Matsumoto K, Inoue H, Watari A, Higashiyama S, Yutsudo M (2006) Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma. Int J Cancer 119(7):1648–1653

    Article  CAS  PubMed  Google Scholar 

  10. Jung TYJS, Lee KH, Cao VT, Jin SG, Moon KS, Kim IY, Kang SS, Kim HS, Lee MC (2011) Nogo-A expression in oligodendroglial tumors. Neuropathology 31(1):11–19

    Article  PubMed  Google Scholar 

  11. Yicun Chen XT, Zhang X, Zhuang L (2009) New mutations of Nogo-C in hepatocellular carcinoma. Mol Biol Rep 36:377–380

    Article  PubMed  Google Scholar 

  12. Novak G, Tallerico T (2006) Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3’-UTR. Brain Res 1120(1):161–171. doi:10.1016/j.brainres.2006.08.071

    Article  CAS  PubMed  Google Scholar 

  13. Novak G, Kim D, Seeman P, Tallerico T (2002) Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res Mol Brain Res 107(2):183–189

    Article  CAS  PubMed  Google Scholar 

  14. Zhou B, Rao L, Li Y, Gao L, Li C, Chen Y, Xue H, Liang W, Lv M, Song Y, Peng Y, Zhang L (2009) The association between dilated cardiomyopathy and RTN4 3’UTR insertion/deletion polymorphisms. Clin Chim Acta 400(1–2):21–24. doi:10.1016/j.cca.2008.09.028

    Article  CAS  PubMed  Google Scholar 

  15. Chen Y, Zhou B, Li H, Peng Y, Wang Y, Rao L (2011) Analysis of RTN4 3’UTR insertion/deletion polymorphisms in ventricular septal defect in a Chinese Han population. DNA Cell Biol 30(5):323–327. doi:10.1089/dna.2010.1116

    Article  CAS  PubMed  Google Scholar 

  16. Shi S, Zhou B, Wang Y, Chen Y, Zhang K, Wang K, Quan Y, Song Y, Rao L, Zhang L (2012) Genetic variation in RTN4 3’-UTR and susceptibility to cervical squamous cell carcinoma. DNA Cell Biol 31(6):1088–1094. doi:10.1089/dna.2011.1548

    Article  CAS  PubMed  Google Scholar 

  17. Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928–1929

    Article  CAS  PubMed  Google Scholar 

  18. Wei TGA, Qian HR, Su C, Helvering LM, Kulkarini NH, Shou J, N'Cho M, Bryant HU, Onyia JE (2007) DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. BMC Womens Health 7:5

    Article  PubMed  Google Scholar 

  19. Hiroshi Ishikawa SR, Demura M, Rademaker AW, Kasai T, Inoue M, Usui H, Shozu M, Bulun SE (2009) High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab 94:1752–1756

    Article  PubMed  Google Scholar 

  20. Ishwad CSFR, Hanley K, Davare J, Meloni AM, Sandberg AA, Surti U (1997) Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosomes Cancer 19:156–160

    Article  CAS  PubMed  Google Scholar 

  21. Xing YPPW, Morton CC (1997) The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Cancer Genet Cytogenet 98(69–74):69

    Article  CAS  PubMed  Google Scholar 

  22. Meloni AMSU, Sandberg AA (1991) Deletion of chromosome 13 in leiomyomas of the uterus. Cancer Genet Cytogenet 53:199–203

    Article  CAS  PubMed  Google Scholar 

  23. Jennelle C, Hodge KTC, Huyck KL, Somasundaram P, Panhuysen CIM, Stewart EA, Morton CC (2009) Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet 125(3):257–263

    Article  Google Scholar 

  24. Bowden WSJ, Kovanci E, Rajkovic A (2009) Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays. Mol Hum Reprod 15(9):563–568

    Article  CAS  PubMed  Google Scholar 

  25. Yaqin Chen SZ, Xiang R (2010) RTN3 and RTN4: candidate modulators in vascular cell apoptosis and atherosclerosis. J Cell Biochem 111:797–800

    Article  PubMed  Google Scholar 

  26. Oertle T, Huber C, van der Putten H, Schwab ME (2003) Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol 325(2):299–323

    Article  CAS  PubMed  Google Scholar 

  27. Yang J, Yu L, Bi AD, Zhao SY (2000) Assignment of the human reticulon 4 gene (RTN4) to chromosome 2p14–2p13 by radiation hybrid mapping. Cytogenet Cell Genet 88(1–2):101–102

    Article  CAS  PubMed  Google Scholar 

  28. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403(6768):439–444. doi:10.1038/35000226

    Article  CAS  PubMed  Google Scholar 

  29. Chen YC, Lu DD, Cao XR, Zhang XR (2005) RTN4-C gene expression in hepatocellular carcinoma and its influence on SMMC7721 cell growth and apoptosis. Yi Chuan Xue Bao 32(9):891–897

    CAS  PubMed  Google Scholar 

  30. Zheng H, Xue S, Lian F, Wang YY (2011) A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway. Med Hypotheses 77(2):278–281. doi:10.1016/j.mehy.2011.04.035

    Article  CAS  PubMed  Google Scholar 

  31. Watari A, Yutsudo M (2003) Multi-functional gene ASY/Nogo/RTN-X/RTN4: apoptosis, tumor suppression, and inhibition of neuronal regeneration. Apoptosis 8(1):5–9

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 30871044, No. 81172440 and No. 30901596), the Applied Basic Research Programs of Science and Technology Commission Foundation of Sichuan Province (No. 2010SZ0122 and No. 2009SZ0163), and by Program for Chang-jiang Scholars and Innovative Research Team in University.

Disclosure Statement

No competing financial interests exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lin Zhang.

Additional information

Kui Zhang and Peng Bai have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, K., Bai, P., Shi, S. et al. Association of Genetic Variations in RTN4 3’-UTR with Risk of Uterine Leiomyomas. Pathol. Oncol. Res. 19, 475–479 (2013). https://doi.org/10.1007/s12253-013-9604-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9604-6

Keywords

Navigation